BNTC News and Press, Benitec Biopharma Limited From 03/30/20

MELBOURNE, Australia , March 30, 2020 /PRNewswire/ -- Benitec Biopharma Limited (Benitec or the "Company") (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today announce that the Supreme Court of Queensland ("Court") has approved the scheme of arrangement to redomicile the Benitec group fr...

MELBOURNE, Australia , March 26, 2020 /PRNewswire/ -- Benitec Biopharma (ASX: BLT, NASDAQ: BNTC) ("Benitec" or the "Company"), a biotechnology company developing novel genetic medicines via the proprietary DNA-directed RNA interference (ddRNAi) platform combining RNA interference wit...

Gainers: vTv Therapeutics (NASDAQ: VTVT )  +57% . More news on: vTv Therapeutics Inc., Taubman Centers, Inc., NanoViricides, Inc., Stocks on the move, , Read more ...

Gainers: Benitec Biopharma (NASDAQ: BNTC )  +51% . More news on: Benitec Biopharma Limited, Assertio Therapeutics, Inc., Ocwen Financial Corporation, Stocks on the move, , Read more ...

Gainers:  Paringa Resources (NASDAQ: PNRL ) +250% . More news on: Paringa Resources Limited, ASLAN Pharmaceuticals Limited, Hepion Pharmaceuticals, Inc., Stocks on the move, Read more ...

MELBOURNE, Australia , Nov. 27, 2019 /PRNewswire/ -- Benitec Biopharma Limited (" Benitec " or the " Company ") (ASX:BLT; NASDAQ:BNTC; NASDAQ:BNTCW) is pleased to announce its intention to redomicile from Australia to the United States of America . To implement the re-domiciliation, Be...

MELBOURNE, Australia , Oct. 31, 2019 /PRNewswire/ -- Benitec Biopharma (ASX: BLT) (NASDAQ: BNTC) ("Benitec" or the "Company"), a biotechnology company developing novel genetic medicines via the proprietary DNA-directed RNA interference (ddRNAi) platform combining RNA interference with gen...

Benitec Biopharma (NASDAQ: BNTC ) has  entered  into a securities purchase agreement ("SPA") with certain investors in U.S.to issue 2.8M American Depositary Shares ("ADSs"), with each ADS representing 20 fully paid ordinary shares, at a purchase price of $0.70/ADS, in a regist...

NEW YORK and MELBOURNE, Australia , Sept. 30, 2019 /PRNewswire/ -- Benitec Biopharma Limited (ASX:BLT; NASDAQ:BNTC; NASDAQ:BNTCW) ("Benitec" or the "Company") announces it has entered into a securities purchase agreement ("SPA") with certain sophisticated and professional investors...

MELBOURNE, Australia , Sept. 19, 2019 /PRNewswire/ -- Benitec Biopharma Ltd (ASX: BLT, NASDAQ: BNTC), a gene therapy-focused biotechnology company developing novel genetic medicines derived from the proprietary DNA-directed RNA interference ("ddRNAi") platform, today announced that Jerel...